276 related articles for article (PubMed ID: 10712203)
1. Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations.
Stokowski RP; Cox DR
Am J Hum Genet; 2000 Mar; 66(3):873-91. PubMed ID: 10712203
[TBL] [Abstract][Full Text] [Related]
2. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.
Surace EI; Haipek CA; Gutmann DH
Oncogene; 2004 Jan; 23(2):580-7. PubMed ID: 14724586
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of neurofibromatosis 2 (NF2) missense mutations.
Gutmann DH; Hirbe AC; Haipek CA
Hum Mol Genet; 2001 Jul; 10(14):1519-29. PubMed ID: 11448944
[TBL] [Abstract][Full Text] [Related]
4. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
[TBL] [Abstract][Full Text] [Related]
5. Binding of the merlin-I product of the neurofibromatosis type 2 tumour suppressor gene to a novel site in beta-fodrin is regulated by association between merlin domains.
Neill GW; Crompton MR
Biochem J; 2001 Sep; 358(Pt 3):727-35. PubMed ID: 11535133
[TBL] [Abstract][Full Text] [Related]
6. Detection of cellular proteins that interact with the NF2 tumor suppressor gene product.
Takeshima H; Izawa I; Lee PS; Safdar N; Levin VA; Saya H
Oncogene; 1994 Aug; 9(8):2135-44. PubMed ID: 8035998
[TBL] [Abstract][Full Text] [Related]
7. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
8. Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin.
Grönholm M; Sainio M; Zhao F; Heiska L; Vaheri A; Carpén O
J Cell Sci; 1999 Mar; 112 ( Pt 6)():895-904. PubMed ID: 10036239
[TBL] [Abstract][Full Text] [Related]
9. Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function.
Yang C; Asthagiri AR; Iyer RR; Lu J; Xu DS; Ksendzovsky A; Brady RO; Zhuang Z; Lonser RR
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4980-5. PubMed ID: 21383154
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesionand spreading.
Gutmann DH; Sherman L; Seftor L; Haipek C; Hoang Lu K; Hendrix M
Hum Mol Genet; 1999 Feb; 8(2):267-75. PubMed ID: 9931334
[TBL] [Abstract][Full Text] [Related]
11. Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2.
Stemmer-Rachamimov AO; Ino Y; Lim ZY; Jacoby LB; MacCollin M; Gusella JF; Ramesh V; Louis DN
J Neuropathol Exp Neurol; 1998 Dec; 57(12):1164-7. PubMed ID: 9862639
[TBL] [Abstract][Full Text] [Related]
12. Defects in neurofibromatosis 2 protein function can arise at multiple levels.
Gutmann DH; Geist RT; Xu Hm; Kim JS; Saporito-Irwin S
Hum Mol Genet; 1998 Mar; 7(3):335-45. PubMed ID: 9466988
[TBL] [Abstract][Full Text] [Related]
13. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
[TBL] [Abstract][Full Text] [Related]
14. Neurofibromatosis 2 tumor suppressor, the gene induced by valproic acid, mediates neurite outgrowth through interaction with paxillin.
Yamauchi J; Miyamoto Y; Kusakawa S; Torii T; Mizutani R; Sanbe A; Nakajima H; Kiyokawa N; Tanoue A
Exp Cell Res; 2008 Jul; 314(11-12):2279-88. PubMed ID: 18486129
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate.
Sun CX; Haipek C; Scoles DR; Pulst SM; Giovannini M; Komada M; Gutmann DH
Hum Mol Genet; 2002 Dec; 11(25):3167-78. PubMed ID: 12444101
[TBL] [Abstract][Full Text] [Related]
16. Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas.
Kimura Y; Saya H; Nakao M
Neuropathology; 2000 Sep; 20(3):153-60. PubMed ID: 11132929
[TBL] [Abstract][Full Text] [Related]
17. Mild familial neurofibromatosis 2 associates with expression of merlin with altered COOH-terminus.
Sainio M; Jääskeläinen J; Pihlaja H; Carpén O
Neurology; 2000 Mar; 54(5):1132-8. PubMed ID: 10720287
[TBL] [Abstract][Full Text] [Related]
18. Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton.
Sainio M; Zhao F; Heiska L; Turunen O; den Bakker M; Zwarthoff E; Lutchman M; Rouleau GA; Jääskeläinen J; Vaheri A; Carpén O
J Cell Sci; 1997 Sep; 110 ( Pt 18)():2249-60. PubMed ID: 9378774
[TBL] [Abstract][Full Text] [Related]
19. Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin.
Shaw RJ; McClatchey AI; Jacks T
Cell Growth Differ; 1998 Apr; 9(4):287-96. PubMed ID: 9563848
[TBL] [Abstract][Full Text] [Related]
20. The neurofibromatosis-2 homologue, Merlin, and the tumor suppressor expanded function together in Drosophila to regulate cell proliferation and differentiation.
McCartney BM; Kulikauskas RM; LaJeunesse DR; Fehon RG
Development; 2000 Mar; 127(6):1315-24. PubMed ID: 10683183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
